Ticker Details
Fulgent Genetics, Inc. Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care.
IPO Date:	September 29, 2016
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$547.55M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.95 | 3.07%
Avg Daily Range (30 D):	$0.40 | 2.09%
Avg Daily Range (90 D):	$0.40 | 2.23%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.32M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	1,997
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$.73M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.8M
Avg Closing Trade (30 D):	$.72M
Avg Closing Trade (90 D):	$1.05M
Avg Closing Volume:	46.28K

News

Apr 17, 2026 @ 7:20 PM Lowey Dannenberg, P.C. is Investigating Fulgent Ge... Source: Lowey Dannenberg P.C.

Mar 20, 2026 @ 12:00 AM FLGT SHAREHOLDER ALERT: Investors Encouraged to Co... Source: Kirby Mcinerney Llp

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Aug 1, 2025 @ 8:26 PM Why Fulgent Genetics Stock Was Crushing It on Frid... Source: Eric Volkman

Jul 15, 2025 @ 11:41 PM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS
Diluted EPS
Revenue	$323.93M	$85.39M	$71.14M
Gross Profit	$115.26M	$25.68M	$21.49M
Net Income / Loss	$-85.47M	$-29.72M	$-25.27M
Operating Income / Loss	$-122.28M	$-36.07M	$-34.62M
Cost of Revenue	$208.67M	$59.71M	$49.65M
Net Cash Flow	$-61.58M	$2.91M	$-26.79M
PE Ratio